Logo image of EIF.DE

MEDNATION AG (EIF.DE) Stock Fundamental Analysis

FRA:EIF - Deutsche Boerse Ag - DE0005653604 - Common Stock - Currency: EUR

1.54  0 (0%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to EIF. EIF was compared to 26 industry peers in the Health Care Providers & Services industry. The financial health of EIF is average, but there are quite some concerns on its profitability. EIF is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

EIF had positive earnings in the past year.
EIF had a positive operating cash flow in the past year.
In multiple years EIF reported negative net income over the last 5 years.
In the past 5 years EIF always reported a positive cash flow from operatings.
EIF.DE Yearly Net Income VS EBIT VS OCF VS FCFEIF.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M

1.2 Ratios

EIF has a worse Return On Assets (0.29%) than 73.08% of its industry peers.
EIF has a worse Return On Equity (0.90%) than 76.92% of its industry peers.
Looking at the Return On Invested Capital, with a value of 2.01%, EIF is doing worse than 73.08% of the companies in the same industry.
EIF had an Average Return On Invested Capital over the past 3 years of 1.75%. This is below the industry average of 6.32%.
The last Return On Invested Capital (2.01%) for EIF is above the 3 year average (1.75%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.29%
ROE 0.9%
ROIC 2.01%
ROA(3y)-0.31%
ROA(5y)-1.7%
ROE(3y)-5.18%
ROE(5y)-13.87%
ROIC(3y)1.75%
ROIC(5y)N/A
EIF.DE Yearly ROA, ROE, ROICEIF.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

With a Profit Margin value of 0.21%, EIF is not doing good in the industry: 76.92% of the companies in the same industry are doing better.
The Operating Margin of EIF (2.95%) is worse than 65.38% of its industry peers.
EIF's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 90.58%, EIF belongs to the top of the industry, outperforming 92.31% of the companies in the same industry.
EIF's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 2.95%
PM (TTM) 0.21%
GM 90.58%
OM growth 3YN/A
OM growth 5Y-8.88%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.52%
GM growth 5Y-0.44%
EIF.DE Yearly Profit, Operating, Gross MarginsEIF.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

More info and screens

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so EIF is destroying value.
The number of shares outstanding for EIF has been reduced compared to 1 year ago.
EIF has less shares outstanding than it did 5 years ago.
EIF has a better debt/assets ratio than last year.
EIF.DE Yearly Shares OutstandingEIF.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M
EIF.DE Yearly Total Debt VS Total AssetsEIF.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

EIF has an Altman-Z score of 1.75. This is a bad value and indicates that EIF is not financially healthy and even has some risk of bankruptcy.
EIF has a Altman-Z score of 1.75. This is comparable to the rest of the industry: EIF outperforms 50.00% of its industry peers.
The Debt to FCF ratio of EIF is 8.55, which is on the high side as it means it would take EIF, 8.55 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 8.55, EIF perfoms like the industry average, outperforming 57.69% of the companies in the same industry.
EIF has a Debt/Equity ratio of 1.06. This is a high value indicating a heavy dependency on external financing.
EIF has a Debt to Equity ratio of 1.06. This is in the lower half of the industry: EIF underperforms 61.54% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.06
Debt/FCF 8.55
Altman-Z 1.75
ROIC/WACC0.58
WACC3.44%
EIF.DE Yearly LT Debt VS Equity VS FCFEIF.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M 50M

2.3 Liquidity

EIF has a Current Ratio of 1.57. This is a normal value and indicates that EIF is financially healthy and should not expect problems in meeting its short term obligations.
EIF has a better Current ratio (1.57) than 76.92% of its industry peers.
A Quick Ratio of 1.38 indicates that EIF should not have too much problems paying its short term obligations.
EIF has a Quick ratio of 1.38. This is amongst the best in the industry. EIF outperforms 84.62% of its industry peers.
Industry RankSector Rank
Current Ratio 1.57
Quick Ratio 1.38
EIF.DE Yearly Current Assets VS Current LiabilitesEIF.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

1

3. Growth

3.1 Past

EIF shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -85.94%.
EIF shows a small growth in Revenue. In the last year, the Revenue has grown by 7.56%.
EIF shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.13% yearly.
EPS 1Y (TTM)-85.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-122.57%
Revenue 1Y (TTM)7.56%
Revenue growth 3Y10.85%
Revenue growth 5Y0.13%
Sales Q2Q%3.33%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EIF.DE Yearly Revenue VS EstimatesEIF.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 77.00, which means the current valuation is very expensive for EIF.
73.08% of the companies in the same industry are cheaper than EIF, based on the Price/Earnings ratio.
EIF's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.91.
Industry RankSector Rank
PE 77
Fwd PE N/A
EIF.DE Price Earnings VS Forward Price EarningsEIF.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

EIF's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. EIF is cheaper than 88.46% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of EIF indicates a rather cheap valuation: EIF is cheaper than 84.62% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 3.33
EV/EBITDA 5.15
EIF.DE Per share dataEIF.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

EIF does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MEDNATION AG

FRA:EIF (7/29/2025, 7:00:00 PM)

1.54

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)09-30 2024-09-30
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners25.13%
Ins Owner ChangeN/A
Market Cap4.80M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 77
Fwd PE N/A
P/S 0.1
P/FCF 3.33
P/OCF 2.08
P/B 0.41
P/tB 0.42
EV/EBITDA 5.15
EPS(TTM)0.02
EY1.3%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.46
FCFY30.01%
OCF(TTM)0.74
OCFY48.14%
SpS15.63
BVpS3.71
TBVpS3.7
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.29%
ROE 0.9%
ROCE 4.73%
ROIC 2.01%
ROICexc 2.23%
ROICexgc 2.23%
OM 2.95%
PM (TTM) 0.21%
GM 90.58%
FCFM 2.96%
ROA(3y)-0.31%
ROA(5y)-1.7%
ROE(3y)-5.18%
ROE(5y)-13.87%
ROIC(3y)1.75%
ROIC(5y)N/A
ROICexc(3y)1.97%
ROICexc(5y)N/A
ROICexgc(3y)1.97%
ROICexgc(5y)N/A
ROCE(3y)4.15%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y6.43%
ROICexc growth 3YN/A
ROICexc growth 5Y6.41%
OM growth 3YN/A
OM growth 5Y-8.88%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.52%
GM growth 5Y-0.44%
F-Score7
Asset Turnover1.35
Health
Industry RankSector Rank
Debt/Equity 1.06
Debt/FCF 8.55
Debt/EBITDA 4.48
Cap/Depr 66.39%
Cap/Sales 1.79%
Interest Coverage 2.13
Cash Conversion 84.1%
Profit Quality 1378.59%
Current Ratio 1.57
Quick Ratio 1.38
Altman-Z 1.75
F-Score7
WACC3.44%
ROIC/WACC0.58
Cap/Depr(3y)35.94%
Cap/Depr(5y)25.78%
Cap/Sales(3y)1.15%
Cap/Sales(5y)1.49%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-85.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-122.57%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)7.56%
Revenue growth 3Y10.85%
Revenue growth 5Y0.13%
Sales Q2Q%3.33%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-20.59%
EBIT growth 3YN/A
EBIT growth 5Y-8.76%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y134.09%
FCF growth 3Y-18.54%
FCF growth 5Y-3.22%
OCF growth 1Y133.4%
OCF growth 3Y-13.99%
OCF growth 5Y-5.06%